Event Type: Webinar, CLE / CPD
- Start Date/Time:
- 22 September 2022, 12:00 PM EDT
- End Date/Time:
- 22 September 2022, 1:00 PM EDT
The legislation also significantly redesigns the Medicare Part D prescription drug program, including major changes to the coverage gap discounts currently paid by manufacturers, to the subsidies CMS provides to Part D plans and to the benefit design, and adds requirements for manufacturers to pay new “inflation rebates” on utilization of drugs covered under Medicare Part B or and Part D under certain circumstances. Such changes will have important implications for drug manufacturers, plan sponsors, pharmacies, drug distributors, pharmacy benefit managers and other industry participants, as well as for patients.
Please join members of Reed Smith’s health care team for a three-part webinar series focused on providing a detailed analysis of and practical guidance related to the drug pricing provisions included in the IRA. Our team members – who have focused on drug pricing regulations for decades – will help manufacturers and other industry participants to understand how they will be impacted by these changes and what steps they need to take now to prepare for these measures taking effect.
Dates and session titles:
- September 22, 2022 at 12pm: Medicare Inflation Rebates
- September 29, 2022 at 12pm: Part D Benefit, Subsidy and Manufacturer Discount Redesign
- October 4, 2022 at 12pm: Medicare Drug Price Negotiation
PLEASE READ – Important CLE information
Each program is presumptively approved for 1.0 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia. Applications for CLE credit will be filed in Delaware, Florida, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance but Reed Smith only provides credit for the states listed. Please allow 4-6 weeks after the program to receive a certificate of attendance.